Abstract
Introduction: To assess the current diagnostic, treatment, and documentation strategies for bladder cancer (BC) in German-speaking countries. Materials and Methods: A 14-item web-based survey was distributed among members of the German, Austrian, and Swiss Associations of Urology, addressing physicians who perform cystoscopies and transurethral resection of bladder tumors (TURB). Results: The survey was responded to by 308 of 5,564 urologists with a mean age of 49.5 years (response rate: 5.5%). The majority of participants (57.3%) practice in an outpatient setting. White light cystoscopy only is used by 60.2%, with additional photodynamic diagnosis and narrow band imaging by 36.8 and 12.5%, respectively. Endoscopic findings are documented in written form by 93.5%, followed by image capture (33.7%) and a central data archive (20.8%). Inpatient hospital urologists document cystoscopic findings by freehand drawing (21.4 vs. 11.4%, p = 0.017), and with a fixed bladder scheme (31.3 vs. 7.4%, <0.05) significantly more frequently. Cystoscopic findings are mainly conveyed to other health professionals in written form (77.4%), and significantly more often by inpatient urologists (p < 0.05). Conclusions: Significant differences exist in the approach to documenting and communicating cystoscopic BC findings. Accurate graphic documentation of lesions, visualization of the mucosa’s totality, and meticulous consultation of previous surgical reports require improvements to reduce recurrence and progression rates.
References
1.
Siegel
RL
, Miller
KD
, Jemal
A
. Cancer statistics, 2019
. CA Cancer J Clin
. 2019
Jan
;69
(1
):7
–34
.
[PubMed]
0007-92352.
Hendricksen
K
, et al. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: results of a European Survey
. Eur Urol Focus
. 2017
.
[PubMed]
2405-45693.
Babjuk
M
, Burger
M
, Comperat
E
, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS)
. European Association of Urology
; 2018
.4.
Rose
TL
, Lotan
Y
. Advancements in optical techniques and imaging in the diagnosis and management of bladder cancer
. Urol Oncol
. 2018
Mar
;36
(3
):97
–102
.
[PubMed]
1078-14395.
Agenant
M
, Noordmans
HJ
, Koomen
W
, Bosch
JL
. Real-time bladder lesion registration and navigation: a phantom study
. PLoS One
. 2013
;8
(1
):e54348
.
[PubMed]
1932-62036.
Lurie
KL
, Angst
R
, Zlatev
DV
, Liao
JC
, Ellerbee Bowden
AK
. 3D reconstruction of cystoscopy videos for comprehensive bladder records
. Biomed Opt Express
. 2017
Mar
;8
(4
):2106
–23
.
[PubMed]
2156-70857.
Campi
R
, Seisen
T
, Roupret
M
; Unmet Clinical Needs and Future Perspectives in Non-muscle-invasive Bladder Cancer
. Unmet Clinical Needs and Future Perspectives in Non-muscle-invasive Bladder Cancer
. Eur Urol Focus
. 2018
Jul
;4
(4
):472
–80
.
[PubMed]
2405-45698.
Li
K
, Xu
Y
, Tan
M
, Xia
S
, Xu
Z
, Xu
D
. A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer
. Lasers Med Sci
. 2019
Feb
;34
(1
):85
–92
.
[PubMed]
0268-89219.
Joudi
FN
, Smith
BJ
, O’Donnell
MA
, Konety
BR
. Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis
. Urology
. 2003
Dec
;62
(6
):1083
–8
.
[PubMed]
0090-429510.
Chung
D
, Hersey
K
, Fleshner
N
. Differences between urologists in United States and Canada in approach to bladder cancer
. Urology
. 2005
May
;65
(5
):919
–25
.
[PubMed]
0090-429511.
Chou
R
, Selph
S
, Buckley
DI
, Fu
R
, Griffin
JC
, Grusing
S
, et al. Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis
. J Urol
. 2017
Mar
;197
(3 Pt 1
):548
–58
.
[PubMed]
0022-534712.
Burger
M
, Grossman
HB
, Droller
M
, Schmidbauer
J
, Hermann
G
, Drăgoescu
O
, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data
. Eur Urol
. 2013
Nov
;64
(5
):846
–54
.
[PubMed]
0302-283813.
Jacqmin
D
, Jichlinski
P
, Molinier
L
, de la Taille
A
, Irani
J
, Malavaud
B
. Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect
. Urol Int
. 2017
;99
(3
):358
–66
.
[PubMed]
0042-113814.
Naito
S
, Algaba
F
, Babjuk
M
, Bryan
RT
, Sun
YH
, Valiquette
L
, et al.; CROES Narrow Band Imaging Global Study Group
. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results
. Eur Urol
. 2016
Sep
;70
(3
):506
–15
.
[PubMed]
0302-283815.
Kang
W
, Cui
Z
, Chen
Q
, Zhang
D
, Zhang
H
, Jin
X
. Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis
. Oncotarget
. 2017
Apr
;8
(14
):23880
–90
.
[PubMed]
1949-255316.
Zhao
C
, Tang
K
, Yang
H
, Xia
D
, Chen
Z
. Bipolar Versus Monopolar Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: A Meta-Analysis
. J Endourol
. 2016
Jan
;30
(1
):5
–12
.
[PubMed]
0892-779017.
Liem
, E.
, et al., Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial. Urol Oncol, 2018
. 36(7): p. 338 e1-338 e11.18.
Ukai
R
, Kawashita
E
, Ikeda
H
. A new technique for transurethral resection of superficial bladder tumor in 1 piece
. J Urol
. 2000
Mar
;163
(3
):878
–9
.
[PubMed]
0022-534719.
Liang
H
, Yang
T
, Wu
K
, He
D
, Fan
J
. En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer
. World J Urol
. 2019
Dec
;37
(12
):2677
–82
.
[PubMed]
0724-498320.
Babjuk
M
. En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
World J Urol
. 2019
Mar
.
[PubMed]
0724-498321.
Péntek
Q
, Hein
S
, Miernik
A
, Reiterer
A
. Image-based 3D surface approximation of the bladder using structure-from-motion for enhanced cystoscopy based on phantom data
. Biomed Tech (Berl)
. 2018
Jul
;63
(4
):461
–6
.
[PubMed]
0013-558522.
Bostrom
PJ
, Toren
PJ
, Xi
H
, Chow
R
, Truong
T
, Liu
J
, et al. Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical records
. J Am Med Inform Assoc
. 2011
Nov-Dec
;18
(6
):835
–41
.
[PubMed]
1067-502723.
Reid
, E.S.
, Djaladat
, H.
, Daneshmand
, S.
The Role of Photodocumentation in Surveillance Cystoscopy for Bladder Cancer.
UIJ, 2017
. 4(5)24.
Cumberbatch
MG
, Foerster
B
, Catto
JW
, Kamat
AM
, Kassouf
W
, Jubber
I
, et al. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review
. Eur Urol
. 2018
Jun
;73
(6
):925
–33
.
[PubMed]
0302-283825.
Schoenthaler
M
, Hein
S
, Seitz
C
, Türk
C
, Danuser
H
, Vach
W
, et al. The stone surgeon in the mirror: how are German-speaking urologists treating large renal stones today?
World J Urol
. 2018
Mar
;36
(3
):467
–73
.
[PubMed]
0724-4983© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
